AI app aims to boost Pill-Taking in underserved youth with epilepsy
NCT ID NCT07445074
First seen Mar 08, 2026 · Last updated May 12, 2026 · Updated 6 times
Summary
This study tests whether a smartphone app called Medilepsy®, which uses artificial intelligence to personalize reminders, can help underserved teens and young adults (ages 14-24) with epilepsy take their anti-seizure medicine more consistently. Participants will use either the AI version or a standard version of the app for a period of time. The goal is to see if the AI version improves medication adherence and readiness to transition to adult healthcare.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Orlando Health
RECRUITINGOrlando, Florida, 32806, United States
Contact
-
University of Central Florida
RECRUITINGOrlando, Florida, 32827, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.